NCT04956198View on ClinicalTrials.gov

Drug Sensitivity and Mutation Profiling

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Ewing SarcomaOsteosarcomaRhabdomyosarcomaWilms TumorSarcoma, Spindle CellSarcoma RhabdoidChildhood Sarcoma of Soft Tissue
Trial Locations (1)

33155

Nicklaus Children's Hospital, Miami

All Listed Sponsors
collaborator

Nicklaus Children's Hospital f/k/a Miami Children's Hospital

OTHER

collaborator

Cornelia T. Bailey Foundation

UNKNOWN

lead

Florida International University

OTHER

NCT04956198 - Drug Sensitivity and Mutation Profiling | Biotech Hunter | Biotech Hunter